User ID (e mail) :
Choose the foods with the lowest fat content. | For really shiny hair, rinse your hair with a mixture of one teaspoon of soda to a cup of warm water. | The oatmeal's soothing anti-inflammatory properties will reduce itching. | Garlic is a popular herbal remedy which is best known for its treatment of coughs and colds. | Banana is also good for cleansing your bowel. | Green barley powder used to fight the growth of cancer cells, Add half teaspoon to half a glass of juice every day | Carrot are filled with natural enzymes and beta carotene,which can help the body resist diseases such as cancer and cardiovascular diseases. | The natural acid from the fruit cuts through fats and aids digestion. | The mineral zinc is essential for the prevention of prostate problems. | Almond oil is a natural cleanser and makeup remover that's gentle even on sensitive skins. |
Search Drug (generic name) :
List of Approved Drugs
for the treatment of adult and pediatric patients with inhalational anthrax due to Bacillus anthracis in combination with appropriate antibacterial drugs, and for prophylaxis of inhalational anthrax when alternative therapies are not available or are not appropriate.
HUMAN GENOME SCIENCES INC.
for the treatment of patients with progressive, metastatic medullary thyroid cancer (MTC).
EFAVIRENZ;LAMIVUDINE;TENOFOVIR DISOPROXIL FUMARATE
EFAVIRENZ, LAMIVUDINE, AND TENOFOVIR DISOPROXIL FUMARATE
HETERO DRUGS LTD
for the treatment of adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response or intolerance to methotrexate. It may be used as monotherapy or in combination with methotrexate or other nonbiologic disease-modifying antirheumatic drugs (DMARDs). XELJANZ should not be used in combination with biologic DMARDs or potent immunosuppressants such as azathioprine and cyclosporine.
Used for the treatment of adult patients with chronic or accelerated phase chronic myeloid leukemia (CML) with resistance and/or intolerance to two or more tyrosine kinase inhibitors (TKI). This indication is based upon response rate. There are no trials verifying an improvement in disease-related symptoms or increased survival with SYNRIBO.
as an adjunctive therapy for the treatment of partial-onset seizures with or without secondarily generalized seizures in patients with epilepsy aged 12 years and older.
Adults: Adjunctive therapy in the treatment of partial seizures; Children: Adjunctive therapy in the treatment of partial seizures in children 6 to 17 years.
for the treatment of symptomatic vitreomacular adhesion.
for the management of moderate to severe acute pain in adults.
for the treatment of corneal cystine crystal accumulation in patients with cystinosis.
This website does not provide online medical consultation or any treatment or any prescription. This website is intended for information puspose only.
Indian Health Services 2011 | All Rights reserved |
Terms and Conditions of Use
Advertise with us